Cristália Produtos Químicos Farmacêuticos Ltda.

This is a very early safety study testing a new treatment called CRIS100 for people who have just suffered a severe spinal cord injury in their upper to mid-back. Five participants will receive a single injection of CRIS100 directly into the injury site within 72 hours of their t…

This early-stage study aims to test the safety and measure blood levels of a new liposome product in healthy adults. The research involves 12 healthy volunteers aged 18-30 who will receive the experimental treatment. Researchers will monitor for side effects and track how the pro…